Biz Oliver Brüstle ve Kök Hücre Mühendisliği Grubu, Bonn Üniversitesi, destek ve değerli tartışmalar için tüm üyelerine teşekkür ediyorum. Sabine Schenk, SDS-PAGE ve proje boyunca kalıcı destek hazırlanması için teşekkür ederiz. Nicole Russ ve Anna Magerhans mükemmel teknik destek sağladı. Ayrıca, biz Andreas Bär ve Sheila Mertens film üretimi için teşekkür etmek istiyorum. Bu çalışma, Volkswagen Vakfı (Az I/77864) ve Alman Eğitim ve Araştırma Bakanlığı (BMBF, 01 GN 0813) hibe tarafından desteklenmiştir.

Ifade vektör ve ifade İnşaat: PSESAME Cre ekspresyon vektörü standart klonlama yöntemleri kullanarak AvrII ve NheI kısıtlama siteleri aracılığıyla pSESAME bir Cre-kodlama parçası takarak inşa edilmiştir. pSESAME histidin etiketi, TAT-domain, NLS sırası ve Cre, kısaltılmış HTNCre oluşan bir füzyon proteini kodlar. HTNCre ifade için pSESAME Cre TUNER (de3) pLacI dönüştü ve bir gliserol stok hazırlamak için kullanılan. <ol><li> Bir gece aşırı kültür gliserol stok dönüştürdü bakteri ile kaplı bir pipetlemeyin ucunu kullanarak ekildi. % 0.5 glukoz ile desteklenmiş LB medya oluşan aşırı gece kültür [v / v] ve 50 mcg / mL nihai konsantrasyonda carbenicillin ve 37 büyümeye izin ° C de 16 saat boyunca. </li><li> Ertesi gün yoğun olarak yetiştirilen üzerinde gece kültürü 1 ila 40 arasında bir oranı ifade kültürünü aşılamak için kullanılan ve 37 ° C&#39;de bir inkübatör konuldu İfade kültürü, son bir 100 mcg / mL konsantrasyonda% 0.5 &#39;lik glukoz [v / v] ve ampisilin ile desteklenmiş TB medya oluşuyordu. </li><li> OD 595 1.5 ifade kültürü 1 saat için 0.5 mM IPTG ile indüklenen </li><li> Daha sonra bakteri SLA3000 rotor 10 dakika 5000 rpm&#39;de santrifüj yoluyla toplanmıştır. </li><li> Bakteriler pelet eksi 20 ° C arıtma kadar saklandı. </li></ol> Hücre geçirgen protein saflaştırılması: <ol><li> Dondurulmuş bakteri pelet oda sıcaklığında 15 dakika başına 10 litre şişesi kültür mL lizis tamponu yeniden süspanse edildi. </li><li> Süspansiyon sonra oda sıcaklığında karıştırılması sırasında, ek 15 dakika boyunca 1 mg / ml lizozim inkübe edildi. </li><li> 25 U / ml Benzonase sonra eklenir ve oda sıcaklığında 15 dakika boyunca karıştırma inkübe edildi. </li><li> Gücünün% 45 0,5 darbeleri ile 1.5 dakika süreyle buz sonification sonra, 1 ml soğuk tartarik tuz tamponu (TSB) başına ml süspansiyon dikkatle süre eklendi karıştırma ve buz üzerinde 5 dakika inkübe. SDS-PAGE lizat fraksiyonu (L) örnek alındı. </li><li> Temizlendi lizat ° C &#39;de 30 dakika 30.000 g. 4 santrifüj yoluyla elde edildi Çözünür (S) ve çözünmez fraksiyonları (I) SDS-PAGE örnekleri alındı. </li><li> Süpernatant taze 50 ml şahin tüpler içine transfer oldu ve 4 az 1 saat sonra hafifçe karıştırılır ° C,% 50 Ni-NTA bulamaç ilk ifade kültür litre başına 2 ml. </li><li> Süspansiyon gravite akışı EconoPac sütunu (fraksiyonu akış ile alınmıştır (FT) SDS-PAGE örnek) ile paketlenir ve 5 yatak yıkama tampon hacimleri ile iki kez yıkandı. Hem yıkama fraksiyonları (W1 ve W2) SDS-PAGE örnekleri alındı. </li><li> HTNCre içeren fraksiyonlar eluat fraksiyonu (E) SDS-PAGE analizi için elüsyon tampon ve örnek 3 yatak hacimleri ile yıkandı alınmıştır. </li><li> Imidazol yüksek tuz tamponu iki kez karşı elüsyon fraksiyonu diyaliz tarafından kaldırıldı. </li><li> Protein solüsyonu gliserol tampon karşı iki kez diyaliz daha fazla konsantre oldu. Tüm diyaliz adımları örnek tampon oranı en az 50 oldu. Bu prosedür, 200 ve 450 mcM arasında bir normal konsantrasyonda HTNCre içeren bir gliserol stok solüsyonu ile sonuçlandı, yani 1 litre ifade kültür ~ 12 mg protein neden olacaktır. Gliserol stoku (GS) SDS-PAGE analizi için örnek toplanmıştır. HTNCre stok solüsyonu eksi 20 saklanabilir ° C </li></ol><img border="0" src="/files/ftp_upload/1627/1627fig1tmb.jpg" alt="Şekil 1" /> Şekil 1: Cre recombinase saflaştırma işlemi sırasında toplanan örneklerin SDS-PAGE analizi. Cre ifade İndüksiyon lizat fraksiyonu egemen grup tarafından gösterilir. Çözünmeyen protein bir parçası olmakla birlikte, eluat ve gliserol stok kesirler görüldüğü gibi Cre proteini daha zenginleştirilmiş olabilir. L: Lizat: çözünmez, S: Süzüntü FT: Akış, W: Yıkama, E: Eluat, GS: Gylcerol Stok. Lütfen Şekil 1&#39;de bir büyük halini görmek için <a href="https://www.jove.com/files/ftp_upload/1627/1627fig1.jpg">buraya tıklayınız</a> . Fare embriyonik kök (ES) hücrelerin içine protein transdüksiyon: <ol><li> Bir koşullu β-galaktosidaz muhabiri 5 inşa taşıyan ES hücrelerinin yapışık hücrelere disosiasyon için TrypLE ™ Express kullanan tek bir hücre olarak seribaşı. 4 ila 6 saat sonra hücrelerin yeniden bağlı olan ve orta kaldırıldı. </li><li> Daha sonra ES hücrelerinin, 16 saat süreyle HTNCre içeren orta inkübe edildi. <ul><li> Gliserol stokunun HTNCre protein uygun bir miktar (10 mcM karşılık), ES, orta ve daha sonra steril filtre (0.22 mm) içine sulandırılmış oldu. </li></ul></li><li> Protein transdüksiyon orta normal büyüme ortamına geri çevrildikten sonra. </li><li> Iki gün hücreler PBS ile yıkanmış ve 10 dakika için% 4 Paraformaldehit (PFA) ile fikse edildi. </li><li> İki ekPBS ile fonksiyonel yıkama adımları X-Gal boyama yapıldı önce idam edildi. </li><li> Sabit hücreleri X-Gal boyama çözüm 6 bir tabaka ile kaplıdır ve gece boyunca 37 ° C&#39;de inkübe edildi. </li></ol> Temsilcisi Sonuçlar: Ertesi gün X-Gal boyama çözüm talip oldu ve hücreler PBS mikroskopi analizi için bir tabaka ile kaplıydı. Recombined hücreleri 80 -% 100 β-galaktosidaz aktivitesi tarafından değerlendirilecektir fare ES hücrelerinin içinde gözlenebilmektedir.

<ol>
	<li>Gump, J. M., Dowdy, S. F. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=TAT+transduction:+the+molecular+mechanism+and+therapeutic+prospects.">TAT transduction: the molecular mechanism and therapeutic prospects.</a> Trends Mol Med. 13 (10), 443-448 (2007).</li><li>Edenhofer, F. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Protein+transduction+revisited:+novel+insights+into+the+mechanism+underlying+intracellular+delivery+of+proteins.">Protein transduction revisited: novel insights into the mechanism underlying intracellular delivery of proteins.</a> Curr Pharm Des. 14 (34), 3628-3636 (2008).</li><li>Branda, C. S., Dymecki, S. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Talking+about+a+revolution:+The+impact+of+site-specific+recombinases+on+genetic+analyses+in+mice.">Talking about a revolution: The impact of site-specific recombinases on genetic analyses in mice.</a> Dev Cell. 6 (1), 7-28 (2004).</li><li>Nolden, L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Site-specific+recombination+in+human+embryonic+stem+cells+induced+by+cell-permeant+Cre+recombinase.">Site-specific recombination in human embryonic stem cells induced by cell-permeant Cre recombinase.</a> Nat Methods. 3 (6), 461-467 (2006).</li><li>Zhang, Y. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Inducible+site-directed+recombination+in+mouse+embryonic+stem+cells.">Inducible site-directed recombination in mouse embryonic stem cells.</a> Nucleic Acids Res. 24 (4), 543-548 (1996).</li><li>Peitz, M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Enhanced+purification+of+cell-permeant+Cre+and+germline+transmission+after+transduction+into+mouse+embryonic+stem+cells.">Enhanced purification of cell-permeant Cre and germline transmission after transduction into mouse embryonic stem cells.</a> Genesis. 45 (8), 508-517 (2007).</li><li>Bosnali, M., Edenhofer, F. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Generation+of+transducible+versions+of+transcription+factors+Oct4+and+Sox2.">Generation of transducible versions of transcription factors Oct4 and Sox2.</a> Biol Chem. 389 (7), 851-861 (2008).</li><li>Landry, J. R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Runx+genes+are+direct+targets+of+Scl/Tal1+in+the+yolk+sac+and+fetal+liver.">Runx genes are direct targets of Scl/Tal1 in the yolk sac and fetal liver.</a> Blood. 111 (6), 3005-3014 (2008).</li></ol>

Cre füzyon protein saflaştırma işlemi sırasında buz TBS tampon ek santrifüj önce atlamak için önemlidir. Aksi takdirde Cre recombinase gliserol tampon içinde çökelti eğilimindedir. Eluat fraksiyonu haline görünüyorsa çözüm yine ortadan kalkıncaya kadar, füzyon proteini ek elüsyon tampon yüksek konsantrasyonu nedeniyle bulanık eklenmelidir. 10 mcM Cre füzyon protein uygulama genellikle 80 ila% 100 arasında bir rekombinasyon verimlilik sonuçlanır. Fötal Buzağı Serumu (FCS) ES hücre ortamın önemli bir bileşeni olan, güçlü bir şekilde protein transdüksiyon inhibe eder. Cre recombinase Bu nedenle yüksek konsantrasyonda kullanılması gerekiyordu. Serum serbest koşullarda çalışırken daha az protein (0.5 - 2 mcM) benzer rekombinasyon verimliliği elde etmek için kullanılabilir. Eldeki pSESAME vektör sistemi ile bir Oct4 ve Sox2 7 ve Scl/Tal1 8 gibi transkripsiyon faktörleri de dahil olmak üzere diğer proteinler protein iletimi tekniği uygulayabilirsiniz.

<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">	
		
		<div>
		<table border="1">
		<thead>
		<tr>
		<th>Material Name</th>
		<th>Type</th>
		<th>Company</th>
		<th>Catalogue Number</th>
		<th>Comment</th>
		</tr>
		</thead>
		<tbody>
		
<tr>
<td>TUNER (DE3) pLacI</td>
<td>&nbsp;</td>
<td>Novagen</td>
<td>70625</td>
<td>&nbsp;</td>
<tr>
<td>Glycerol</td>
<td>&nbsp;</td>
<td>Carl Roth</td>
<td>3783.2</td>
<td>&nbsp;</td>
<tr>
<td>Na2HPO4</td>
<td>&nbsp;</td>
<td>Roth</td>
<td>T876.1</td>
<td>&nbsp;</td>
<tr>
<td>Trizma Base</td>
<td>&nbsp;</td>
<td>Sigma-Aldrich</td>
<td>T1503</td>
<td>&nbsp;</td>
<tr>
<td>HCl</td>
<td>&nbsp;</td>
<td>Roth</td>
<td>4625.1</td>
<td>&nbsp;</td>
<tr>
<td>Imidazol</td>
<td>&nbsp;</td>
<td>Roth</td>
<td>X998.4</td>
<td>&nbsp;</td>
<tr>
<td>NaCl</td>
<td>&nbsp;</td>
<td>Roth</td>
<td>9265.2</td>
<td>&nbsp;</td>
<tr>
<td>Yeast Extract</td>
<td>&nbsp;</td>
<td>Roth</td>
<td>2363.4</td>
<td>&nbsp;</td>
<tr>
<td>Trypton/Pepton</td>
<td>&nbsp;</td>
<td>Roth</td>
<td>8952.4</td>
<td>&nbsp;</td>
<tr>
<td>K2HPO4 </td>
<td>&nbsp;</td>
<td>Roth</td>
<td>P749.2</td>
<td>&nbsp;</td>
<tr>
<td>KH2PO4</td>
<td>&nbsp;</td>
<td>Roth</td>
<td>3904.1</td>
<td>&nbsp;</td>
<tr>
<td>Ampicillin</td>
<td>&nbsp;</td>
<td>Sigma</td>
<td>A9518</td>
<td>&nbsp;</td>
<tr>
<td>Carbenicillin</td>
<td>&nbsp;</td>
<td>Sigma</td>
<td>6344.2</td>
<td>&nbsp;</td>
<tr>
<td>HEPES</td>
<td>&nbsp;</td>
<td>Sigma</td>
<td>H3375</td>
<td>&nbsp;</td>
<tr>
<td>Lysozyme</td>
<td>&nbsp;</td>
<td>Sigma</td>
<td>62971</td>
<td>&nbsp;</td>
<tr>
<td>Benzonase</td>
<td>&nbsp;</td>
<td>Novagen</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<tr>
<td>L-Tartaric acid, disodium salt </td>
<td>&nbsp;</td>
<td>Sigma</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<tr>
<td>50% Ni-NTA slurry</td>
<td>&nbsp;</td>
<td>Invitrogen</td>
<td>R901-15</td>
<td>&nbsp;</td>
<tr>
<td>EconoPac columns</td>
<td>&nbsp;</td>
<td>Biorad</td>
<td>732-1010</td>
<td>&nbsp;</td>
<tr>
<td>Sterile filter 0,22&mu;m</td>
<td>&nbsp;</td>
<td>Whatman</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<tr>
<td>Paraformaldehyde (PFA)</td>
<td>&nbsp;</td>
<td>Sigma</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<tr>
<td>LB medium</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>Yeast extract, Trypton/Pepton, NaCl</td>
</tr>
<tr>
<td>TB medium</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>Yeast extract, Trypton/Pepton, Glycerol, K2HPO4, KH2PO4</td>
</tr>
<tr>
<td>Lysis Buffer</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>50 mM Na2HPO4, 5 mM Tris, pH 7.8</td>
</tr>
<tr>
<td>Tartaric Salt Buffer (TSB)</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>PTB containing 2 M L-Tartaric acid, disodium salt, and 20 mM Imidazol</td>
</tr>
<tr>
<td>Washing Buffer</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>PTB, 500 mM NaCl, 15 mM Imidazol</td>
</tr>
<tr>
<td>Elution Buffer</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>PTB, 500 mM NaCl, 250 mM Imidazol</td>
</tr>
<tr>
<td>High Salt Buffer</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>600 mM NaCl, 20 mM HEPES, pH 7.4</td>
</tr>
<tr>
<td>Gylcerol Buffer</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>50% glycerol, 500 mM NaCl, 20 mM HEPES, pH 7.4</td>
</tr>
<tr>
<td>TrypLE&trade; Express</td>
<td>&nbsp;</td>
<td>Invitrogen</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<tr>
<td>ESGRO (LIF)</td>
<td>&nbsp;</td>
<td>Millipore</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<tr>
<td>NEAA</td>
<td>&nbsp;</td>
<td>Gibco</td>
<td>11140035</td>
<td>&nbsp;</td>
<tr>
<td>L-Glutamin</td>
<td>&nbsp;</td>
<td>Gibco</td>
<td>25030024</td>
<td>&nbsp;</td>
<tr>
<td>&beta;-Mercaptoethanol</td>
<td>&nbsp;</td>
<td>Gibco</td>
<td>31350010</td>
<td>&nbsp;</td>
<tr>
<td>DMEM</td>
<td>&nbsp;</td>
<td>Gibco</td>
<td>11960044</td>
<td>&nbsp;</td>
<tr>
<td>PBS</td>
<td>&nbsp;</td>
<td>Gibco</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<tr>
<td>Fetal Calf Serum (FCS)</td>
<td>&nbsp;</td>
<td>PAA</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<tr>
<td>X-Gal staining solution:</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>4 mM K3(FeIII(CN)6), 4 mM K4(FeII(CN)6), 2mM MgCl2 0.4 mg/mL X-Gal solved in PBS</td>
</tr>
<tr>
<td>K3(FeIII(CN)6)</td>
<td>&nbsp;</td>
<td>Sigma</td>
<td>P-3367</td>
<td>&nbsp;</td>
<tr>
<td>K4 (FeII(CN)6)</td>
<td>&nbsp;</td>
<td>Sigma</td>
<td>P-9387</td>
<td>&nbsp;</td>
<tr>
<td>MgCl2</td>
<td>&nbsp;</td>
<td>Sigma</td>
<td>M8266</td>
<td>&nbsp;</td>
<tr>
<td>X-Gal</td>
<td>&nbsp;</td>
<td>Sigma</td>
<td>B4252</td>
<td>&nbsp;</td>		</tbody>
		</table>
		</div>

engineering cell-permeable protein

Protein iletim tekniği, memeli hücrelerinin içine biyolojik aktif madde doğrudan teslim sağlar [1,2 inceleme için bakınız] . Bu yüzden adı verilen hücre delici peptidler (ABM&#39;lerini) translocating yeteneği kullanmak için, aynı zamanda protein transdüksiyon domain (PTDs) olarak belirlenmiş. Insan immün yetmezlik virüsü tip 1 (HIV-1) Tat (trans-transkripsiyon aktivatörü) protein yaygın olarak kullanılmaya başlanmıştır türetilen TAT-CPP. Olumlu ücret TAT, böylece hücre zarının endositoz ve / veya doğrudan membran penetrasyonu 2 engellerinin aşılması hücre geçirgenliğini artırır . Bir nükleer lokalizasyon sinyal ile birlikte (NLS) füzyon proteinleri çekirdeği sergileyen işlevselliği girebilecekler. Bizim video sunumu hücre geçirgen proteinlerin mühendislik, inşaat, üretim ve geçirgen bir hücre DNA modifiye enzim Cre sürümü uygulaması için bir örneklendirme olarak gösteriyor. Cre memeli hücrelerinde in vitro ve in vivo olarak 34 baz çifti loxP siteleri tanımak ve rekombinasyona bir siteye özgü recombinase . Bu nedenle Cre / loxP sistemi yaygın koşullu canlı hücreler 3,4 genom mutasyonları ikna etmek için kullanılır. Ancak, hücreleri aktif Cre recombinase teslim bir sınırlama temsil eder. Biz, gen-faiz doğrudan bir ekleme verir ve hızla uygun ve standart bir şekilde vektör içinde kullanılan farklı etki alanları ve etiketler clone bir platform sağlar pSESAME vektör sistemi açıklanmaktadır. Farklı etiketler yeniden düzenlenmesi, daha yüksek verim ve daha iyi çözünürlük elde etmek için bir olasılık sağlayan füzyon proteinlerin biyokimyasal özellikleri değiştirmek için gösterilmiştir. Ve E. coli hücre permeant rekombinant proteinleri ifade ve arındırmak için nasıl gösterilmektedir. Rekombinant Cre protein işlevselliğini nihayet hücre kültürü, hücre içi recombinase faaliyet değerlendirerek doğrulanır.

Watch this Scientific Journal Video about Engineering Cell-permeable Protein at JoVE.com

Engineering Cell-permeable Protein

Protein transdüksiyon biyolojik olarak aktif proteinler hücre içine doğrudan teslim sağlar. DNA transfeksiyon veya viral transdüksiyon gibi geleneksel yöntemler yerine, aksine bu non-invaziv bir paradigma hücresel toksisite ve kalıcı genetik modifikasyon onkojenik transformasyon riskini engellemeyi titrasyon bir şekilde yüksek verimli hücresel manipülasyon sağlar.

Mühendislik Hücre geçirgen Protein

The protein transduction technique enables the direct delivery of biologically active material into mammalian cells [for review see 1,2]. For this one can ...

Research

JoVE Journal

Biology

14.4K Görüntüleme.  University of Bonn - Life & Brain Center and Hertie Foundation. Protein transdüksiyon biyolojik olarak aktif proteinler hücre içine doğrudan teslim sağlar. DNA transfeksiyon veya viral transdüksiyon gibi geleneksel yöntemler yerine, aksine bu non-invaziv bir paradigma hücresel toksisite ve kalıcı genetik modifikasyon onkojenik transformasyon riskini engellemeyi titrasyon bir şekilde yüksek verimli hücresel manipülasyon sağlar.

Video: Engineering Cell-permeable Protein

Experimental Approaches to Tissue Engineering

Doku Mühendisliği Deneysel Yaklaşımlar

Biyoloji

Micro-scale Engineering for Cell Biology

Hücre Biyolojisi Mikro ölçekli Mühendisliği

Staining of Proteins in Gels with Coomassie G-250 without Organic Solvent and Acetic Acid

In classical protein staining protocols using Coomassie Brilliant Blue (CBB), solutions with high contents of toxic and flammable organic solvents (Methanol, Ethanol or 2-Propanol) and acetic acid are used for fixation, staining and destaining of proteins in a gel after SDS-PAGE. To speed up the procedure, heating the staining solution in the microwave oven for a short time is frequently used. This usually results in evaporation of toxic or hazardous Methanol, Ethanol or 2-Propanol and a strong smell of acetic acid in the lab which should be avoided due to safety considerations. In a protocol originally published in two patent applications by E.M. Wondrak (US2001046709 (A1), US6319720 (B1)), an alternative composition of the staining solution is described in which no organic solvent or acid is used. The CBB is dissolved in bidistilled water (60-80mg of CBB G-250 per liter) and 35 mM HCl is added as the only other compound in the staining solution. The CBB staning of the gel is done after SDS-PAGE and thorough washing of the gel in bidistilled water. By heating the gel during the washing and staining steps, the process can be finished faster and no toxic or hazardous compunds are evaporating. The staining of proteins occurs already within 1 minute after heating the gel in staining solution and is fully developed after 15-30 min with a slightly blue background that is destained completely by prolonged washing of the stained gel in bidistilled water, without affecting the stained protein bands.

A short protocol for protein staining with Coomassie Brilliant Blue (CBB) G-250 in polyacrylamide gels is described without using organic solvents or acetic acid as in the classical staining procedures with CBB.

Organik Solvent ve Asetik Asit olmadan Jeller Coomassie G-250 ile Proteinlerin Boyama

In classical protein staining protocols using Coomassie Brilliant Blue (CBB), solutions with high contents of toxic and flammable organic solvents ...

Cellular Encapsulation in 3D Hydrogels for Tissue Engineering 

The 3D encapsulation of cells within hydrogels represents an increasingly important and popular technique for culturing cells and towards the development of constructs for tissue engineering. This environment better mimics what cells observe in vivo, compared to standard tissue culture, due to the tissue-like properties and 3D environment. Synthetic polymeric hydrogels are water-swollen networks that can be designed to be stable or to degrade through hydrolysis or proteolysis as new tissue is deposited by encapsulated cells. A wide variety of polymers have been explored for these applications, such as poly(ethylene glycol) and hyaluronic acid. Most commonly, the polymer is functionalized with reactive groups such as methacrylates or acrylates capable of undergoing crosslinking through various mechanisms. In the past decade, much progress has been made in engineering these microenvironments - e.g., via the physical or pendant covalent incorporation of biochemical cues - to improve viability and direct cellular phenotype, including the differentiation of encapsulated stem cells (Burdick et al.).
The following methods for the 3D encapsulation of cells have been optimized in our and other laboratories to maximize cytocompatibility and minimize the number of hydrogel processing steps. In the following protocols (see Figure 1 for an illustration of the procedure), it is assumed that functionalized polymers capable of undergoing crosslinking are already in hand; excellent reviews of polymer chemistry as applied to the field of tissue engineering may be found elsewhere (Burdick et al.) and these methods are compatible with a range of polymer types. Further, the Michael-type addition (see Lutolf et al.) and light-initiated free radical (see Elisseeff et al.) mechanisms focused on here constitute only a small portion of the reported crosslinking techniques. Mixed mode crosslinking, in which a portion of reactive groups is first consumed by addition crosslinking and followed by a radical mechanism, is another commonly used and powerful paradigm for directing the phenotype of encapsulated cells (Khetan et al., Salinas et al.).

Cellular Encapsulation in 3D Hydrogels for Tissue Engineering

We present protocols for the 3-dimensional (3D) encapsulation of cells within synthetic hydrogels. The encapsulation procedure is outlined for two commonly used methods of crosslinking (michael-type addition and light-initiated free radical mechanisms), as well as a number of techniques for assessing encapsulated cell behavior.

Doku Mühendisliği 3D Hidrojeller Hücresel Kapsülleme

The 3D encapsulation of cells within hydrogels represents an increasingly important and popular technique for culturing cells and towards the development ...

Using the GELFREE 8100 Fractionation System for Molecular Weight-Based Fractionation with Liquid Phase Recovery

The GELFREE 8100 Fractionation System is a novel protein fractionation system designed to maximize protein recovery during molecular weight based fractionation. The system is comprised of single-use, 8-sample capacity cartridges and a benchtop GELFREE Fractionation Instrument. During separation, a constant voltage is applied between the anode and cathode reservoirs, and each protein mixture is electrophoretically driven from a loading chamber into a specially designed gel column gel. Proteins are concentrated into a tight band in a stacking gel, and separated based on their respective electrophoretic mobilities in a resolving gel. As proteins elute from the column, they are trapped and concentrated in liquid phase in the collection chamber, free of the gel. The instrument is then paused at specific time intervals, and fractions are collected using a pipette. This process is repeated until all desired fractions have been collected. If fewer than 8 samples are run on a cartridge, any unused chambers can be used in subsequent separations.
This novel technology facilitates the quick and simple separation of up to 8 complex protein mixtures simultaneously, and offers several advantages when compared to previously available fractionation methods. This system is capable of fractionating up to 1mg of total protein per channel, for a total of 8mg per cartridge. Intact proteins over a broad mass range are separated on the basis of molecular weight, retaining important physiochemical properties of the analyte. The liquid phase entrapment provides for high recovery while eliminating the need for band or spot cutting, making the fractionation process highly reproducible1.

The accompanying video describes the use of the GELFREE 8100 Fractionation System, which partitions complex protein samples on the basis of molecular weight and recovers the fractions in liquid phase. The video describes how the technology works, how it is used, and provides resultant data, with polyacrylamide gel electrophoresis analysis of fractionated bovine liver homogenate.

Sıvı Faz Kurtarma Moleküler Ağırlık Tabanlı Fraksiyonu GELFREE 8100 Fraksiyonu Sisteminin Kullanılması

The GELFREE 8100 Fractionation System is a novel protein fractionation system designed to maximize protein recovery during molecular weight based ...

Imaging Protein-protein Interactions in vivo

Protein-protein interactions are a hallmark of all essential cellular processes. However, many of these interactions are transient, or energetically weak, preventing their identification and analysis through traditional biochemical methods such as co-immunoprecipitation. In this regard, the genetically encodable fluorescent proteins (GFP, RFP, etc.) and their associated overlapping fluorescence spectrum have revolutionized our ability to monitor weak interactions in vivo using F&ouml;rster resonance energy transfer (FRET)1-3. Here, we detail our use of a FRET-based proximity assay for monitoring receptor-receptor interactions on the endothelial cell surface.

Imaging Protein-protein Interactions in vivo

This protocol describes how to image protein-protein interactions using a FRET-based proximity assay.

Görüntüleme Protein-protein etkileşimleri In vivo</em

Protein-protein interactions are a hallmark of all essential cellular processes. However, many of these interactions are transient, or energetically weak, ...

Automated Hydrophobic Interaction Chromatography Column Selection for Use in Protein Purification

In contrast to other chromatographic methods for purifying proteins (e.g. gel filtration, affinity, and ion exchange), hydrophobic interaction chromatography (HIC) commonly requires experimental determination (referred to as screening or "scouting") in order to select the most suitable chromatographic medium for purifying a given protein 1. The method presented here describes an automated approach to scouting for an optimal HIC media to be used in protein purification.
HIC separates proteins and other biomolecules from a crude lysate based on differences in hydrophobicity. Similar to affinity chromatography (AC) and ion exchange chromatography (IEX), HIC is capable of concentrating the protein of interest as it progresses through the chromatographic process. Proteins best suited for purification by HIC include those with hydrophobic surface regions and able to withstand exposure to salt concentrations in excess of 2 M ammonium sulfate ((NH4)2SO4). HIC is often chosen as a purification method for proteins lacking an affinity tag, and thus unsuitable for AC, and when IEX fails to provide adequate purification. Hydrophobic moieties on the protein surface temporarily bind to a nonpolar ligand coupled to an inert, immobile matrix. The interaction between protein and ligand are highly dependent on the salt concentration of the buffer flowing through the chromatography column, with high ionic concentrations strengthening the protein-ligand interaction and making the protein immobile (i.e. bound inside the column) 2. As salt concentrations decrease, the protein-ligand interaction dissipates, the protein again becomes mobile and elutes from the column. Several HIC media are commercially available in pre-packed columns, each containing one of several hydrophobic ligands (e.g. S-butyl, butyl, octyl, and phenyl) cross-linked at varying densities to agarose beads of a specific diameter 3. Automated column scouting allows for an efficient approach for determining which HIC media should be employed for future, more exhaustive optimization experiments and protein purification runs 4.
The specific protein being purified here is recombinant green fluorescent protein (GFP); however, the approach may be adapted for purifying other proteins with one or more hydrophobic surface regions. GFP serves as a useful model protein, due to its stability, unique light absorbance peak at 397 nm, and fluorescence when exposed to UV light 5. Bacterial lysate containing wild type GFP was prepared in a high-salt buffer, loaded into a Bio-Rad DuoFlow medium pressure liquid chromatography system, and adsorbed to HiTrap HIC columns containing different HIC media. The protein was eluted from the columns and analyzed by in-line and post-run detection methods. Buffer blending, dynamic sample loop injection, sequential column selection, multi-wavelength analysis, and split fraction eluate collection increased the functionality of the system and reproducibility of the experimental approach.

An automated method for identifying suitable hydrophobic interaction chromatography (HIC) media to be used in the process of protein purification is presented. The method utilizes a medium-pressure liquid chromatography system including automated buffer blending, dynamic sample loop injection, sequential column selection, multi-wavelength analysis, and split fraction eluate collection.

Protein Saflaştırma Kullanım için Otomatik Hidrofobik Etkileşim Kromatografisi Sütun Seçimi

In contrast to other chromatographic methods for purifying proteins (e.g. gel filtration, affinity, and ion exchange), hydrophobic interaction ...

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules

The aim of de novo protein design is to find the amino acid sequences that will fold into a desired 3-dimensional structure with improvements in specific properties, such as binding affinity, agonist or antagonist behavior, or stability, relative to the native sequence. Protein design lies at the center of current advances drug design and discovery. Not only does protein design provide predictions for potentially useful drug targets, but it also enhances our understanding of the protein folding process and protein-protein interactions. Experimental methods such as directed evolution have shown success in protein design. However, such methods are restricted by the limited sequence space that can be searched tractably. In contrast, computational design strategies allow for the screening of a much larger set of sequences covering a wide variety of properties and functionality. We have developed a range of computational de novo protein design methods capable of tackling several important areas of protein design. These include the design of monomeric proteins for increased stability and complexes for increased binding affinity.
To disseminate these methods for broader use we present Protein WISDOM (<a href="http://www.proteinwisdom.org" target="_blank">http://www.proteinwisdom.org</a>), a tool that provides automated methods for a variety of protein design problems. Structural templates are submitted to initialize the design process. The first stage of design is an optimization sequence selection stage that aims at improving stability through minimization of potential energy in the sequence space. Selected sequences are then run through a fold specificity stage and a binding affinity stage. A rank-ordered list of the sequences for each step of the process, along with relevant designed structures, provides the user with a comprehensive quantitative assessment of the design. Here we provide the details of each design method, as well as several notable experimental successes attained through the use of the methods.

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules

We developed computational de novo protein design methods capable of tackling several important areas of protein design. To disseminate these methods we present Protein WISDOM, an online tool for protein design (<a href="http://www.proteinwisdom.org" target="_blank">http://www.proteinwisdom.org</a>). Starting from a structural template, design of monomeric proteins for increased stability and complexes for increased binding affinity can be performed.

Protein AKIL: A Tezgahı<em&gt; Siliko olarak</em&gt;<em&gt; De novo</emBiyomoleküllerin&gt; Tasarım

The aim of de novo protein design is to find the amino acid sequences that will fold into a desired 3-dimensional structure with improvements in specific ...

Mouse Genome Engineering Using Designer Nucleases

Transgenic mice carrying site-specific genome modifications (knockout, knock-in) are of vital importance for dissecting complex biological systems as well as for modeling human diseases and testing therapeutic strategies. Recent advances in the use of designer nucleases such as zinc finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), and the clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated (Cas) 9 system for site-specific genome engineering open the possibility to perform rapid targeted genome modification in virtually any laboratory species without the need to rely on embryonic stem (ES) cell technology. A genome editing experiment typically starts with identification of designer nuclease target sites within a gene of interest followed by construction of custom DNA-binding domains to direct nuclease activity to the investigator-defined genomic locus. Designer nuclease plasmids are in vitro transcribed to generate mRNA for microinjection of fertilized mouse oocytes. Here, we provide a protocol for achieving targeted genome modification by direct injection of TALEN mRNA into fertilized mouse oocytes.

Designer nucleases such as zinc finger nucleases (ZFNs) and transcription activator-like effector nucleases (TALENs) can be used to modify the genome of mouse preimplantation embryos by triggering both the nonhomologous end joining (NHEJ) and homologous recombination (HR) pathways. These advances enable the rapid generation of mice with precise genetic modifications.

Tasarımcı nükleazlar kullanılması Fare Genom Mühendisliği

Transgenic mice carrying site-specific genome modifications (knockout, knock-in) are of vital importance for dissecting complex biological systems as well ...

siRNA Screening to Identify Ubiquitin and Ubiquitin-like System Regulators of Biological Pathways in Cultured Mammalian Cells

Post-translational modification of proteins with ubiquitin and ubiquitin-like molecules (UBLs) is emerging as a dynamic cellular signaling network that regulates diverse biological pathways including the hypoxia response, proteostasis, the DNA damage response and transcription.&#160; To better understand how UBLs regulate pathways relevant to human disease, we have compiled a human siRNA &#8220;ubiquitome&#8221; library consisting of 1,186 siRNA duplex pools targeting all known and predicted components of UBL system pathways. This library can be screened against a range of cell lines expressing reporters of diverse biological pathways to determine which UBL components act as positive or negative regulators of the pathway in question.&#160; Here, we describe a protocol utilizing this library to identify ubiquitome-regulators of the HIF1A-mediated cellular response to hypoxia using a transcription-based luciferase reporter.&#160; An initial assay development stage is performed to establish suitable screening parameters of the cell line before performing the screen in three stages: primary, secondary and tertiary/deconvolution screening. &#160;The use of targeted over whole genome siRNA libraries is becoming increasingly popular as it offers the advantage of reporting only on members of the pathway with which the investigators are most interested.&#160; Despite inherent limitations of siRNA screening, in particular false-positives caused by siRNA off-target effects, the identification of genuine novel regulators of the pathways in question outweigh these shortcomings, which can be overcome by performing a series of carefully undertaken control experiments.

Here, we describe a methodology to perform a targeted siRNA &#8220;ubiquitome&#8221; screen to identify novel ubiquitin and ubiquitin-like regulators of the HIF1A-mediated cellular response to hypoxia.&#160; This can be adapted to any biological pathway where a robust read out of reporter activity is available.

Kültür Memeli Hücrelerde Biyolojik tanımında ubikitin ve Ubiquitin benzeri Sistemi Regülatörleri tanımak siRNA Eleme

Post-translational modification of proteins with ubiquitin and ubiquitin-like molecules (UBLs) is emerging as a dynamic cellular signaling network that ...